http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100478536-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 |
| filingDate | 2002-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100478536-B1 |
| titleOfInvention | Pharmaceutical Composition consisting of L-2-oxothiazolidine-4-carboxylic acid or its salts for asthma therapeutic agent |
| abstract | The present invention relates to an asthma treatment composition containing L-2-oxothiazolidine-4-carboxylic acid or a salt thereof as an active ingredient, L-2-oxothiazolidine-4-carboxylic acid or a salt thereof Decreased the number of inflammatory cells increased by Ovalbumin in asthma model mice and had an excellent asthma inhibitory effect by inhibiting airway hypersensitivity induced by Ovalbumin. |
| priorityDate | 2002-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.